Amdocs Total Current Liabilities vs Non Currrent Assets Other Analysis

DOX Stock

USD 87.30 1.63 1.90%

Amdocs financial indicator trend analysis is way more than just evaluating Amdocs prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Amdocs is a good investment. Please check the relationship between Amdocs Total Current Liabilities and its Non Currrent Assets Other accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.

Total Current Liabilities vs Non Currrent Assets Other

Total Current Liabilities vs Non Currrent Assets Other Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Amdocs Total Current Liabilities account and Non Currrent Assets Other. At this time, the significance of the direction appears to have strong relationship.

The correlation between Amdocs' Total Current Liabilities and Non Currrent Assets Other is 0.65. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Non Currrent Assets Other in the same time period over historical financial statements of Amdocs, assuming nothing else is changed. The correlation between historical values of Amdocs' Total Current Liabilities and Non Currrent Assets Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Amdocs are associated (or correlated) with its Non Currrent Assets Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Currrent Assets Other has no effect on the direction of Total Current Liabilities i.e., Amdocs' Total Current Liabilities and Non Currrent Assets Other go up and down completely randomly.

Correlation Coefficient

0.65

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Total Current Liabilities

Total Current Liabilities is an item on Amdocs balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Amdocs are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Most indicators from Amdocs' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Amdocs current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.At this time, Amdocs' Sales General And Administrative To Revenue is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to rise to 15.40 in 2024, whereas Selling General Administrative is likely to drop slightly above 390.6 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	1.6B	1.7B	2.0B	1.1B
Total Revenue	4.6B	4.9B	5.6B	3.1B

Gross Profit Total Revenue

Amdocs fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock Total Equity	Property Plant And Equipment Gross	Common Stock	Current Deferred Revenue	Other Liab
Total Assets		0.56	0.51	0.95	0.96	0.65	0.2	0.77	0.05	0.43	0.97	0.75	0.44	0.93	-0.88	0.65	0.73	-0.61	0.94	0.81	0.04	0.95	0.64	0.94	0.53	0.95
Short Long Term Debt Total	0.56		0.5	0.44	0.49	0.73	0.53	0.76	-0.2	-0.22	0.68	0.67	-0.25	0.67	-0.76	0.61	0.85	-0.77	0.57	0.15	0.11	0.62	0.73	0.63	0.09	0.47
Other Current Liab	0.51	0.5		0.37	0.32	0.84	0.77	0.77	-0.43	-0.04	0.59	0.75	0.03	0.37	-0.71	0.85	0.71	-0.82	0.67	0.19	-0.33	0.51	0.84	0.55	0.55	0.5
Total Current Liabilities	0.95	0.44	0.37		0.97	0.48	-0.01	0.69	0.3	0.48	0.88	0.65	0.52	0.92	-0.77	0.47	0.65	-0.46	0.82	0.86	0.13	0.94	0.47	0.92	0.47	0.87
Total Stockholder Equity	0.96	0.49	0.32	0.97		0.46	-0.06	0.67	0.28	0.54	0.87	0.64	0.55	0.93	-0.75	0.45	0.66	-0.41	0.8	0.89	0.23	0.92	0.45	0.9	0.38	0.86
Property Plant And Equipment Net	0.65	0.73	0.84	0.48	0.46		0.82	0.93	-0.48	-0.02	0.74	0.9	0.0	0.55	-0.86	0.98	0.87	-0.95	0.79	0.28	-0.32	0.66	1.0	0.7	0.57	0.67
Net Debt	0.2	0.53	0.77	-0.01	-0.06	0.82		0.6	-0.72	-0.47	0.39	0.57	-0.45	0.13	-0.58	0.79	0.53	-0.84	0.48	-0.28	-0.52	0.2	0.82	0.26	0.41	0.3
Retained Earnings	0.77	0.76	0.77	0.69	0.67	0.93	0.6		-0.19	0.1	0.81	0.95	0.16	0.72	-0.9	0.89	0.95	-0.9	0.81	0.49	-0.12	0.82	0.93	0.85	0.54	0.75
Accounts Payable	0.05	-0.2	-0.43	0.3	0.28	-0.48	-0.72	-0.19		0.34	-0.11	-0.17	0.43	0.14	0.24	-0.48	-0.1	0.47	-0.2	0.4	0.12	0.11	-0.49	0.07	-0.22	-0.06
Cash	0.43	-0.22	-0.04	0.48	0.54	-0.02	-0.47	0.1	0.34		0.2	0.17	0.96	0.21	-0.03	0.1	0.06	0.24	0.27	0.84	0.14	0.33	-0.03	0.3	0.21	0.31
Non Current Assets Total	0.97	0.68	0.59	0.88	0.87	0.74	0.39	0.81	-0.11	0.2		0.76	0.2	0.93	-0.96	0.71	0.77	-0.74	0.97	0.63	-0.01	0.93	0.73	0.93	0.51	0.94
Non Currrent Assets Other	0.75	0.67	0.75	0.65	0.64	0.9	0.57	0.95	-0.17	0.17	0.76		0.25	0.66	-0.83	0.9	0.91	-0.82	0.79	0.52	-0.19	0.78	0.9	0.81	0.56	0.77
Cash And Short Term Investments	0.44	-0.25	0.03	0.52	0.55	0.0	-0.45	0.16	0.43	0.96	0.2	0.25		0.22	-0.05	0.13	0.1	0.19	0.29	0.87	0.05	0.37	-0.01	0.34	0.34	0.37
Net Receivables	0.93	0.67	0.37	0.92	0.93	0.55	0.13	0.72	0.14	0.21	0.93	0.66	0.22		-0.87	0.49	0.74	-0.58	0.83	0.67	0.23	0.93	0.54	0.92	0.34	0.86
Common Stock Shares Outstanding	-0.88	-0.76	-0.71	-0.77	-0.75	-0.86	-0.58	-0.9	0.24	-0.03	-0.96	-0.83	-0.05	-0.87		-0.81	-0.84	0.89	-0.94	-0.48	0.06	-0.89	-0.85	-0.91	-0.53	-0.88
Non Current Liabilities Total	0.65	0.61	0.85	0.47	0.45	0.98	0.79	0.89	-0.48	0.1	0.71	0.9	0.13	0.49	-0.81		0.8	-0.89	0.81	0.34	-0.4	0.63	0.98	0.67	0.64	0.69
Other Current Assets	0.73	0.85	0.71	0.65	0.66	0.87	0.53	0.95	-0.1	0.06	0.77	0.91	0.1	0.74	-0.84	0.8		-0.83	0.72	0.44	-0.05	0.78	0.86	0.8	0.4	0.65
Other Stockholder Equity	-0.61	-0.77	-0.82	-0.46	-0.41	-0.95	-0.84	-0.9	0.47	0.24	-0.74	-0.82	0.19	-0.58	0.89	-0.89	-0.83		-0.76	-0.14	0.25	-0.62	-0.95	-0.67	-0.53	-0.64
Total Liab	0.94	0.57	0.67	0.82	0.8	0.79	0.48	0.81	-0.2	0.27	0.97	0.79	0.29	0.83	-0.94	0.81	0.72	-0.76		0.64	-0.18	0.88	0.79	0.89	0.64	0.95
Total Current Assets	0.81	0.15	0.19	0.86	0.89	0.28	-0.28	0.49	0.4	0.84	0.63	0.52	0.87	0.67	-0.48	0.34	0.44	-0.14	0.64		0.15	0.75	0.26	0.72	0.43	0.72
Short Term Debt	0.04	0.11	-0.33	0.13	0.23	-0.32	-0.52	-0.12	0.12	0.14	-0.01	-0.19	0.05	0.23	0.06	-0.4	-0.05	0.25	-0.18	0.15		0.09	-0.32	0.05	-0.41	-0.09
Common Stock Total Equity	0.95	0.62	0.51	0.94	0.92	0.66	0.2	0.82	0.11	0.33	0.93	0.78	0.37	0.93	-0.89	0.63	0.78	-0.62	0.88	0.75	0.09		0.65	1.0	0.44	0.89
Property Plant And Equipment Gross	0.64	0.73	0.84	0.47	0.45	1.0	0.82	0.93	-0.49	-0.03	0.73	0.9	-0.01	0.54	-0.85	0.98	0.86	-0.95	0.79	0.26	-0.32	0.65		0.69	0.57	0.67
Common Stock	0.94	0.63	0.55	0.92	0.9	0.7	0.26	0.85	0.07	0.3	0.93	0.81	0.34	0.92	-0.91	0.67	0.8	-0.67	0.89	0.72	0.05	1.0	0.69		0.47	0.91
Current Deferred Revenue	0.53	0.09	0.55	0.47	0.38	0.57	0.41	0.54	-0.22	0.21	0.51	0.56	0.34	0.34	-0.53	0.64	0.4	-0.53	0.64	0.43	-0.41	0.44	0.57	0.47		0.63
Other Liab	0.95	0.47	0.5	0.87	0.86	0.67	0.3	0.75	-0.06	0.31	0.94	0.77	0.37	0.86	-0.88	0.69	0.65	-0.64	0.95	0.72	-0.09	0.89	0.67	0.91	0.63

Click cells to compare fundamentals

Amdocs Account Relationship Matchups

Amdocs fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	6.3B	6.5B	6.4B	6.4B	7.4B	4.5B
Other Current Liab	794.4M	851.9M	787.1M	802.0M	922.3M	968.4M
Total Current Liabilities	1.2B	1.3B	1.3B	1.4B	1.6B	1.0B
Total Stockholder Equity	3.6B	3.6B	3.5B	3.5B	4.1B	2.8B
Property Plant And Equipment Net	903.4M	931.9M	971.2M	951.9M	1.1B	1.1B
Net Debt	50.0M	172.1M	253.5M	287.2M	258.5M	271.4M
Retained Earnings	5.3B	5.9B	6.2B	6.5B	7.5B	7.9B
Accounts Payable	110.1M	121.2M	134.4M	293.3M	337.3M	394.9M
Cash	983.2M	709.1M	573.4M	520.1M	598.1M	720.1M
Non Current Assets Total	4.3B	4.4B	4.4B	4.5B	5.2B	2.6B
Non Currrent Assets Other	488.6M	630.7M	574.9M	631.6M	726.3M	762.6M
Cash And Short Term Investments	983.9M	965.6M	818.0M	742.5M	853.9M	1.0B
Net Receivables	861.0M	866.8M	946.8M	944.5M	1.1B	618.6M
Common Stock Shares Outstanding	133.2M	128.0M	121.9M	118.5M	106.6M	144.3M
Liabilities And Stockholders Equity	6.3B	6.5B	6.4B	6.4B	7.4B	4.5B
Non Current Liabilities Total	1.5B	1.6B	1.6B	1.5B	1.7B	1.8B
Other Current Assets	229.6M	235.1M	238.4M	224.6M	258.3M	307.0M
Other Stockholder Equity	(1.7B)	(2.3B)	(2.6B)	(3.0B)	(2.7B)	(2.5B)
Total Liab	2.7B	2.9B	2.8B	2.9B	3.3B	1.7B
Total Current Assets	2.1B	2.1B	2.0B	1.9B	2.2B	1.9B
Short Term Debt	159.1M	58.7M	43.3M	40.0M	46.0M	43.7M
Property Plant And Equipment Gross	903.4M	931.9M	971.2M	951.9M	1.1B	1.1B
Accumulated Other Comprehensive Income	11.7M	9.3M	(72.5M)	(53.3M)	(47.9M)	(45.5M)
Common Stock	4.5M	4.5M	4.5M	4.6M	5.3M	4.4M
Current Deferred Revenue	126.8M	237.4M	253.7M	170.6M	196.2M	184.3M
Other Liab	542.4M	586.2M	750.3M	793.9M	913.0M	469.4M
Other Assets	423.9M	488.6M	630.7M	574.9M	661.2M	386.6M
Good Will	2.6B	2.6B	2.7B	2.7B	3.2B	1.9B
Intangible Assets	296.3M	259.0M	178.3M	181.5M	163.4M	317.6M
Property Plant Equipment	354.0M	723.6M	931.9M	971.2M	1.1B	1.2B
Short Term Investments	752K	256.5M	244.6M	222.5M	200.2M	266.3M
Net Tangible Assets	660.6M	567.8M	711.0M	676.6M	609.0M	676.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Amdocs Stock Analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Amdocs Total Current Liabilities vs Non Currrent Assets Other Analysis

Total Current Liabilities vs Non Currrent Assets Other

Total Current Liabilities vs Non Currrent Assets Other Correlation Analysis

Correlation Coefficient

Total Current Liabilities

Non Currrent Assets Other

Amdocs fundamental ratios Correlations

Amdocs Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Amdocs fundamental ratios Accounts

Also Currently Popular

Additional Tools for Amdocs Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Common Stock	+ 1.0	Common Stock Total Equity
Non Current Liabilities Total	+ 0.98	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 0.98	Non Current Liabilities Total
Non Current Assets Total	+ 0.97	Total Assets
Total Stockholder Equity	+ 0.97	Total Current Liabilities

Common Stock Shares Outstanding	- 0.96	Non Current Assets Total
Property Plant And Equipment Gross	- 0.95	Other Stockholder Equity
Other Stockholder Equity	- 0.95	Property Plant And Equipment Net
Total Liab	- 0.94	Common Stock Shares Outstanding
Common Stock	- 0.91	Common Stock Shares Outstanding
Other Stockholder Equity	- 0.9	Retained Earnings